Targeted therapeutic options based on the pathogenesis of IgA nephropathy
1. 系统已在2026-04-02 15:43:13对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
S Bo, A Sun, W Yang, X Wang…
Nephrology Dialysis …, 2026
academic.oup.com
… Immunoglobulin A nephropathy (IgAN) remains the leading … of sibeprelimab in a broader range of IgAN patients. In the … It is worth noting that this treatment regimen does not increase …

